Pura Vida Investments’s Integra LifeSciences IART Stock Holding History

Pura Vida Investments’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-52,700	Closed	-$2.17M	–	97
2023 Q2	$2.17M	Sell	52,700 -55,300	-51%	-$2.66M	0.29%	63
2023 Q1	$6.2M	Sell	108,000 -93,500	-46%	-$5.27M	0.63%	42
2022 Q4	$11.3M	Buy	+201,500	New	+$10.3M	0.58%	41
2022 Q3	–	Sell	-123,900	Closed	-$6.69M	–	225
2022 Q2	$6.69M	Hold	123,900	–	–	0.39%	69
2022 Q1	$7.96M	Buy	123,900 +700	+0.6%	+$46.1K	0.26%	94
2021 Q4	$8.25M	Sell	123,200 -121,900	-50%	-$8.25M	0.3%	84
2021 Q3	$16.8M	Buy	+245,100	New	+$17.3M	0.51%	49
2021 Q2	–	Sell	-165,400	Closed	-$11.4M	–	245
2021 Q1	$11.4M	Buy	+165,400	New	+$11.2M	0.33%	64

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pura Vida Investments's IART Position: Q3 2019 in Review

Pura Vida Investments sold out of Integra LifeSciences (IART) in Q3 2019, closing a stake of 25,000 shares — an estimated $1.4M sold.

Pura Vida Investments first reported a position in IART in Q2 2019 and held it in 1 quarter. The position peaked at $1.4M in Q2 2019. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

Pura Vida Investments reported no remaining Integra LifeSciences position as of Q3 2019 after selling out during the quarter.
Pura Vida Investments sold 25,000 Integra LifeSciences shares in Q3 2019, an estimated $1.4M.
Pura Vida Investments first reported a position in Integra LifeSciences in Q2 2019 and held it in 1 quarter.
Pura Vida Investments's Integra LifeSciences position peaked at $1.4M in Q2 2019.
280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Pura Vida Investments's 13F filing for Q3 2019, filed 14 Nov 2019.